As we enter Q3 2026, global partners are shifting from spot procurement to advance scheduling. Our production capacity for the R-Alpha Lipoic Acid (R-ALA) series is now almost fully booked through October, with Q4 slots open for reservation.
For commercial-stage projects, long-term supply resilience—batch quality consistency, stable delivery, and rapid technical support—outweighs short-term spot pricing.
Tailored Solutions Across Our R-ALA Portfolio:
To support diverse dosage forms (tablets, capsules, solid beverages), we offer customized particle sizes and bulk densities to optimize flowability and compressibility:
• R-ALA
• R-ALA Sodium & Direct-Compressible Granules
• Coated R-ALA Granules
• R-ALA Tromethamine
Plan Your Q4 Sourcing Ahead
Advance planning ensures seamless delivery schedules and dedicated production slots for your commercial requirements.
